177 related articles for article (PubMed ID: 15289937)
1. TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells.
Secchiero P; Zerbinati C; Rimondi E; Corallini F; Milani D; Grill V; Forti G; Capitani S; Zauli G
Cell Mol Life Sci; 2004 Aug; 61(15):1965-74. PubMed ID: 15289937
[TBL] [Abstract][Full Text] [Related]
2. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.
Secchiero P; Gonelli A; Carnevale E; Milani D; Pandolfi A; Zella D; Zauli G
Circulation; 2003 May; 107(17):2250-6. PubMed ID: 12668516
[TBL] [Abstract][Full Text] [Related]
3. BAG3 promotes the phenotypic transformation of primary rat vascular smooth muscle cells via TRAIL.
Fu Y; Chang Y; Chen S; Li Y; Chen Y; Sun G; Yu S; Ye N; Li C; Sun Y
Int J Mol Med; 2018 May; 41(5):2917-2926. PubMed ID: 29484366
[TBL] [Abstract][Full Text] [Related]
4. 17β-Estradiol inhibits TNF-α-induced proliferation and migration of vascular smooth muscle cells via suppression of TRAIL.
Li H; Cheng Y; Simoncini T; Xu S
Gynecol Endocrinol; 2016 Jul; 32(7):581-6. PubMed ID: 26878683
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt.
Morel J; Audo R; Hahne M; Combe B
J Biol Chem; 2005 Apr; 280(16):15709-18. PubMed ID: 15684417
[TBL] [Abstract][Full Text] [Related]
6. Insulin promotes vascular smooth muscle cell proliferation and apoptosis via differential regulation of tumor necrosis factor-related apoptosis-inducing ligand.
Harith HH; Di Bartolo BA; Cartland SP; Genner S; Kavurma MM
J Diabetes; 2016 Jul; 8(4):568-78. PubMed ID: 26333348
[TBL] [Abstract][Full Text] [Related]
7. The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.
Mühlenbeck F; Schneider P; Bodmer JL; Schwenzer R; Hauser A; Schubert G; Scheurich P; Moosmayer D; Tschopp J; Wajant H
J Biol Chem; 2000 Oct; 275(41):32208-13. PubMed ID: 10807904
[TBL] [Abstract][Full Text] [Related]
8. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
[TBL] [Abstract][Full Text] [Related]
9. TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptor.
Kavurma MM; Schoppet M; Bobryshev YV; Khachigian LM; Bennett MR
J Biol Chem; 2008 Mar; 283(12):7754-62. PubMed ID: 18178561
[TBL] [Abstract][Full Text] [Related]
10. Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death.
Keogh RJ; Harris LK; Freeman A; Baker PN; Aplin JD; Whitley GS; Cartwright JE
Circ Res; 2007 Mar; 100(6):834-41. PubMed ID: 17322170
[TBL] [Abstract][Full Text] [Related]
11. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.
Lin Y; Devin A; Cook A; Keane MM; Kelliher M; Lipkowitz S; Liu ZG
Mol Cell Biol; 2000 Sep; 20(18):6638-45. PubMed ID: 10958661
[TBL] [Abstract][Full Text] [Related]
12. TRAIL regulates normal erythroid maturation through an ERK-dependent pathway.
Secchiero P; Melloni E; Heikinheimo M; Mannisto S; Di Pietro R; Iacone A; Zauli G
Blood; 2004 Jan; 103(2):517-22. PubMed ID: 12969966
[TBL] [Abstract][Full Text] [Related]
13. Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sjögren's syndrome.
Matsumura R; Umemiya K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M; Kayagaki N; Yagita H; Okumura K
Clin Exp Rheumatol; 2002; 20(6):791-8. PubMed ID: 12508770
[TBL] [Abstract][Full Text] [Related]
14. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
Zauli G; Rimondi E; Nicolin V; Melloni E; Celeghini C; Secchiero P
Blood; 2004 Oct; 104(7):2044-50. PubMed ID: 15213096
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution of the death ligand TRAIL and its receptors.
Spierings DC; de Vries EG; Vellenga E; van den Heuvel FA; Koornstra JJ; Wesseling J; Hollema H; de Jong S
J Histochem Cytochem; 2004 Jun; 52(6):821-31. PubMed ID: 15150291
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.
Milani D; Zauli G; Rimondi E; Celeghini C; Marmiroli S; Narducci P; Capitani S; Secchiero P
J Neurochem; 2003 Jul; 86(1):126-35. PubMed ID: 12807432
[TBL] [Abstract][Full Text] [Related]
17. Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: mechanisms of PDGF-BB-mediated VSMC proliferation and migration.
Azahri NS; Di Bartolo BA; Khachigian LM; Kavurma MM
J Cell Biochem; 2012 Aug; 113(8):2597-606. PubMed ID: 22415975
[TBL] [Abstract][Full Text] [Related]
18. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
[TBL] [Abstract][Full Text] [Related]
19. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
[TBL] [Abstract][Full Text] [Related]
20. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
